Schroder Investment Management Group
VNDA icon

Schroder Investment Management Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Schroder Investment Management Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-307,176
Closed -$1.45M – 1265
2025
Q2 		$1.45M Sell
307,176
-359,285
-54% -$1.57M ﹤0.01% 954
2025
Q1 		$3.13M Sell
666,461
-371,559
-36% -$1.73M ﹤0.01% 845
2024
Q4 		$4.96M Hold
1,038,020
– – ﹤0.01% 772
2024
Q3 		$4.85M Sell
1,038,020
-117,407
-10% -$629K 0.01% 789
2024
Q2 		$6.53M Buy
+1,155,427
New +$5.97M 0.01% 726

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Schroder Investment Management Group's VNDA Position: Q3 2025 in Review

Schroder Investment Management Group sold out of Vanda Pharmaceuticals (VNDA) in Q3 2025, closing a stake of 307,176 shares — an estimated $1.45M sold.

Schroder Investment Management Group first reported a position in VNDA in Q2 2024 and held it in 5 quarters. The position peaked at $6.53M in Q2 2024. 150 funds tracked by Wall St. Rank hold VNDA as of Q3 2025.

  • Schroder Investment Management Group reported no remaining Vanda Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 307,176 Vanda Pharmaceuticals shares in Q3 2025, an estimated $1.45M.
  • Schroder Investment Management Group first reported a position in Vanda Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • Schroder Investment Management Group's Vanda Pharmaceuticals position peaked at $6.53M in Q2 2024.
  • 150 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2025.

Based on Schroder Investment Management Group's 13F filing for Q3 2025, filed 13 Nov 2025.